Evidence map›Paper›PMID 42272086›Full record

SynthesisJournal of paediatrics and child health2026

Prevalence, Comparative Risk, and Predictors of Shock in Children With Multisystem Inflammatory Syndrome Associated With COVID-19: A Systematic Review and Meta-Analysis.

Asif Jan, Bushra Waheed, Ghadah Ali Hussein, Pratima Pandey, Huma Sultana, Shubham Kumar, Mequanente Dagnaw

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of paediatrics and child health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Asif JanDepartment of Pharmacy, University of Peshawar, Peshawar, KP, Pakistan.ORCID https://orcid.org/0000-0003-3880-5579
Bushra WaheedDepartment of Pharmacy, University of Swabi, Swabi, KP, Pakistan.
Ghadah Ali HusseinCollege of Medical and Health Technologies, Al-Zahraa University for Women, Karbala, Iraq.
Pratima PandeyDepartment of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, India.ORCID https://orcid.org/0009-0006-2761-4151
Huma SultanaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, MS Ramaiah University of Applied Sciences, Bangalore, India.ORCID https://orcid.org/0009-0002-6214-4408
Shubham KumarDental Research Cell, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (Deemed To Be University), Pune, India.
Mequanente DagnawDepartment of Epidemiology and Biostatistics, Institute of Public Health, University of Gondar, Gondar, Ethiopia.ORCID https://orcid.org/0000-0002-4387-8425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultisystem inflammatory syndrome in children (MIS-C) is a severe hyperinflammatory condition associated with SARS-CoV-2 infection and is frequently complicated by cardiovascular dysfunction, particularly shock. Early recognition of shock in MIS-C is critical to reduce morbidity and mortality.

objectiveThis systematic review and meta-analysis aimed to evaluate the prevalence, comparative risk, and predictors of shock among children with MIS-C, enhancing clinical management and informing future research.

methodsA systematic search of PubMed, Embase and Web of Science was conducted from database inception to 15 July 2025. Observational studies reporting prevalence, comparative risk or predictors of shock in children with MIS-C were included. Random-effects meta-analysis with Freeman-Tukey double arcsine transformation was used to estimate pooled prevalence with 95% confidence intervals (CI). Relative risks (RR) were pooled for comparative analyses. Subgroup analyses, sensitivity analyses and meta-regression were performed to explore heterogeneity. Publication bias was assessed using funnel plots and Egger's regression test.

resultsSeventy studies involving 13 263 children with MIS-C were included. The pooled prevalence of shock was 56% (95% CI: 49%-63%), although substantial heterogeneity was observed (I

conclusionThe certainty of evidence ranged from very low to low because of substantial heterogeneity, imprecision and methodological variability across studies. Despite these limitations, shock remains a frequent and serious complication of MIS-C, highlighting the importance of early cardiovascular assessment and timely recognition of high-risk children.

Indexed as

COVID-19ShockSystemic Inflammatory Response SyndromeChildHumansPrevalenceRisk Factorschild healthgood health and well‐beingmeta‐analysismultisystem inflammatory syndrome in childrenSARS‐CoV‐2shock

Identifiers

PMID42272086
PMCPMC13480730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.